BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32596800)

  • 1. The Distinct Role of the Extra-Large G Protein ɑ-Subunit XLɑs.
    Wang Y; Tian H; Chen X
    Calcif Tissue Int; 2020 Sep; 107(3):212-219. PubMed ID: 32596800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.
    Xie Y; Chen X; Xie Y; Yu X
    Clin Genet; 2023 Sep; 104(3):279-286. PubMed ID: 37249323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.
    Richard N; Molin A; Coudray N; Rault-Guillaume P; Jüppner H; Kottler ML
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1549-56. PubMed ID: 23884777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAS mutations and heterotopic ossification.
    Bastepe M
    Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans.
    Lebrun M; Richard N; Abeguilé G; David A; Coëslier Dieux A; Journel H; Lacombe D; Pinto G; Odent S; Salles JP; Taieb A; Gandon-Laloum S; Kottler ML
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3028-38. PubMed ID: 20427508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.
    Pignolo RJ; Xu M; Russell E; Richardson A; Kaplan J; Billings PC; Kaplan FS; Shore EM
    J Bone Miner Res; 2011 Nov; 26(11):2647-55. PubMed ID: 21812029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas.
    Linglart A; Mahon MJ; Kerachian MA; Berlach DM; Hendy GN; Jüppner H; Bastepe M
    Endocrinology; 2006 May; 147(5):2253-62. PubMed ID: 16484323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense mutation in the non-neural G-protein alpha-subunit isoforms modulates susceptibility to obesity.
    Kelly ML; Moir L; Jones L; Whitehill E; Anstee QM; Goldin RD; Hough A; Cheeseman M; Jansson JO; Peters J; Cox RD
    Int J Obes (Lond); 2009 May; 33(5):507-18. PubMed ID: 19238158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.
    Weinstein LS; Yu S; Warner DR; Liu J
    Endocr Rev; 2001 Oct; 22(5):675-705. PubMed ID: 11588148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudopseudohypoparathyroidism and genomic imprinting].
    Minagawa M
    Clin Calcium; 2007 Aug; 17(8):1229-33. PubMed ID: 17660620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinting the Gnas locus.
    Plagge A; Kelsey G
    Cytogenet Genome Res; 2006; 113(1-4):178-87. PubMed ID: 16575178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
    Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
    Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets.
    Freson K; Izzi B; Labarque V; Van Helvoirt M; Thys C; Wittevrongel C; Bex M; Bouillon R; Godefroid N; Proesmans W; de Zegher F; Jaeken J; Van Geet C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4851-9. PubMed ID: 18812479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.
    Weinstein LS; Xie T; Zhang QH; Chen M
    Pharmacol Ther; 2007 Aug; 115(2):271-91. PubMed ID: 17588669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.
    Hanna P; Grybek V; Perez de Nanclares G; Tran LC; de Sanctis L; Elli F; Errea J; Francou B; Kamenicky P; Linglart L; Pereda A; Rothenbuhler A; Tessaris D; Thiele S; Usardi A; Shoemaker AH; Kottler ML; Jüppner H; Mantovani G; Linglart A
    J Bone Miner Res; 2018 Aug; 33(8):1480-1488. PubMed ID: 29693731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review.
    Ma J; Mo W; Sun J; Li Y; Han T; Mao H
    BMC Musculoskelet Disord; 2023 Mar; 24(1):247. PubMed ID: 37003989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
    Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
    Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paternally inherited gsα mutation impairs adipogenesis and potentiates a lean phenotype in vivo.
    Liu JJ; Russell E; Zhang D; Kaplan FS; Pignolo RJ; Shore EM
    Stem Cells; 2012 Jul; 30(7):1477-85. PubMed ID: 22511293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.